The program is still filling in: most podium sessions list one speaker so far, and 228 people on the speaker list have no session yet. We’ll add their talks and organizations as SLAS publishes them.

New modalities at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

5 organizations at SLAS2027 present work in new modalities: 3 academic, nonprofit and media organizations and 2 drug developers. Between them they bring 9 presentations to the program. Most represented: University of California, Los Angeles (4 on the program), University of Texas at Austin (3 on the program), Pfizer (2 on the program). As of Oct 17, 2026.

All 542 organizations at SLAS2027 →

Showing 1–5 of 5 organizations

Organization	SLAS2027 Attendance
University of California, Los Angeles Los Angeles, CA
ucla.edu Academic Public research university and medical center in Los Angeles.	Talk Tue Feb 2 10:30–10:55am Part of Patient-Derived Cell Models for Functional Precision Medicine Talk, title to be announced Room 7AB Cell culture and 3D models Session Tue Feb 2 2–2:45pm Academic Drug Discovery Room 8 Assay development and screening Session Wed Feb 3 1:30–3:30pm Emerging Next-Generation Cellular Therapies Ballroom 6E New modalities 2pmTalk, title to be announced Also Presenting at the meeting, beyond the sessions above
University of Texas at Austin Austin, TX
utexas.edu Academic Public research university in Austin, Texas.	Session Tue Feb 2 3–5pm Driving Innovation in Hybrid Therapeutic Modalities (i.e., ADC, siRNA) Ballroom 6E New modalities 4:30pmDelivery of RNA Therapeutics: How Do We Tackle the 900 Pound Endosomal Escape Gorilla? Also Presenting at the meeting, beyond the sessions above
Pfizer New York, NY
pfizer.com Biopharma Pharmaceutical company developing medicines and vaccines in oncology, inflammation, rare disease and infectious disease.	Session Mon Feb 1 10am–12pm Expanding Induced Proximity Paradigms Beyond Traditional Targeted Protein Degradation (TPD) Ballroom 6E New modalities Session Mon Feb 1 2–2:45pm Encoded Libraries and Biophyscial Lead Discovery Ballroom 6F Assay development and screening
University of Southern California Los Angeles, CA
usc.edu Academic Private research university in Los Angeles.	Session Mon Feb 1 1–1:45pm HCS/HCA Data and Informatics Ballroom 6F Detection and imaging · Software, data and AI Session Wed Feb 3 10am–12pm Advancing Next-Generation Drug Delivery Platforms Across Diverse Therapeutic Modalities Ballroom 6E New modalities
Neomorph San Diego, CA
neomorph.com Biopharma Biotech developing molecular glue degraders that direct disease-causing proteins for destruction.	Session Tue Feb 2 10am–12pm Harnessing Machine Learning and Generative AI to Transform Therapeutic Discovery and Design Ballroom 6E New modalities 10:30amBuilding AI/ML-Ready Multimodal Data Resources at Scale

Instantly find 20 buyers in new modalities

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction

Instantly find 20 buyers in new modalities

Browse SLAS2027 by